• Net cash used in operating activities of $447,000 in Q1 2025
• Cash and cash equivalents of $794,000 at end of quarter
• Funding facility of $254,000 secured against FY25 R&D claim

Intelicare Holdings Ltd has released its Appendix 4C quarterly cashflow report for the quarter ended 31 March 2025. The report shows that the company had net cash used in operating activities of $447,000 during the quarter, compared to $1,102,000 for the first 9 months of the financial year. The company had cash and cash equivalents of $794,000 at the end of the quarter, down from $1,260,000 in the previous quarter. Intelicare has also secured a $254,000 funding facility, which is secured against its FY25 R&D claim. The company is continuing its process to reduce operating cash flows, and believes that it will be able to continue its operations and meet its business objectives. Intelicare is evaluating options to raise further cash to fund its operations and is confident that additional funding will be secured.